tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Ratios

Compare
688 Followers

Ascendis Pharma Ratios

ASND's free cash flow for Q4 2025 was €0.89. For the 2025 fiscal year, ASND's free cash flow was decreased by € and operating cash flow was €0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.04 1.04 1.17 0.95 1.29
Quick Ratio
0.76 0.76 0.84 0.67 1.11
Cash Ratio
0.58 0.58 0.62 0.53 0.62
Solvency Ratio
-0.14 -0.14 -0.28 -0.48 -0.68
Operating Cash Flow Ratio
0.05 0.05 -0.34 -0.63 -0.69
Short-Term Operating Cash Flow Coverage
0.11 0.11 -0.62 -1.11 -1.20
Net Current Asset Value
€ -356.25M€ -356.25M€ -224.34M€ -268.56M€ 97.08M
Leverage Ratios
Debt-to-Assets Ratio
0.67 0.67 0.73 0.90 0.57
Debt-to-Equity Ratio
-5.35 -5.35 -8.10 -5.10 2.35
Debt-to-Capital Ratio
1.23 1.23 1.14 1.24 0.70
Long-Term Debt-to-Capital Ratio
1.73 1.73 1.41 2.88 0.27
Financial Leverage Ratio
-8.00 -8.00 -11.16 -5.67 4.14
Debt Service Coverage Ratio
-0.15 -0.23 -0.53 -0.90 -1.20
Interest Coverage Ratio
-0.86 -1.69 -4.26 -10.34 -18.31
Debt to Market Cap
0.07 0.08 0.11 0.10 0.08
Interest Debt Per Share
16.79 15.66 15.93 13.98 11.56
Net Debt to EBITDA
-3.17 -2.24 -1.02 -0.85 -0.33
Profitability Margins
Gross Profit Margin
86.28%85.08%87.83%83.36%76.28%
EBIT Margin
-13.70%-18.92%-84.63%-161.25%-1069.17%
EBITDA Margin
-11.24%-16.47%-79.76%-154.16%-1034.07%
Operating Profit Margin
-19.00%-18.92%-76.66%-170.79%-1097.85%
Pretax Profit Margin
-29.59%-29.53%-102.64%-177.77%-1129.12%
Net Profit Margin
-31.72%-31.67%-103.97%-180.51%-1139.63%
Continuous Operations Profit Margin
-31.72%-31.67%-103.97%-180.51%-1139.63%
Net Income Per EBT
107.21%107.23%101.30%101.54%100.93%
EBT Per EBIT
155.76%156.05%133.89%104.08%102.85%
Return on Assets (ROA)
-17.49%-16.82%-32.05%-58.32%-53.52%
Return on Equity (ROE)
127.54%134.58%357.68%330.44%-221.45%
Return on Capital Employed (ROCE)
-58.50%-56.16%-102.63%-511.40%-150.64%
Return on Invested Capital (ROIC)
-18.95%-18.19%-36.53%-86.85%-70.25%
Return on Tangible Assets
-17.54%-16.87%-32.16%-58.63%-53.76%
Earnings Yield
-1.85%-1.99%-4.91%-7.51%-9.12%
Efficiency Ratios
Receivables Turnover
4.55 4.39 2.19 7.43 4.30
Payables Turnover
1.09 1.14 0.46 0.47 0.12
Inventory Turnover
0.33 0.34 0.15 0.21 0.09
Fixed Asset Turnover
4.90 4.72 3.68 2.41 0.40
Asset Turnover
0.55 0.53 0.31 0.32 0.05
Working Capital Turnover Ratio
20.26 7.18 6.10 3.09 0.11
Cash Conversion Cycle
861.12 828.84 1.81K 989.36 976.35
Days of Sales Outstanding
80.15 83.18 166.90 49.09 84.95
Days of Inventory Outstanding
1.12K 1.07K 2.44K 1.72K 3.93K
Days of Payables Outstanding
335.74 320.56 794.97 777.49 3.04K
Operating Cycle
1.20K 1.15K 2.60K 1.77K 4.01K
Cash Flow Ratios
Operating Cash Flow Per Share
0.83 0.85 -5.29 -8.30 -8.84
Free Cash Flow Per Share
0.70 0.72 -5.31 -8.35 -9.10
CapEx Per Share
0.14 0.13 0.02 0.04 0.26
Free Cash Flow to Operating Cash Flow
0.84 0.84 1.00 1.01 1.03
Dividend Paid and CapEx Coverage Ratio
6.10 6.35 -214.57 -191.38 -34.21
Capital Expenditure Coverage Ratio
6.10 6.35 -214.57 -191.38 -34.21
Operating Cash Flow Coverage Ratio
0.06 0.06 -0.36 -0.63 -0.80
Operating Cash Flow to Sales Ratio
0.07 0.07 -0.84 -1.75 -9.69
Free Cash Flow Yield
0.35%0.40%-4.00%-7.32%-7.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-54.11 -50.22 -20.36 -13.32 -10.97
Price-to-Sales (P/S) Ratio
17.17 15.90 21.17 24.05 124.97
Price-to-Book (P/B) Ratio
-75.71 -67.58 -72.81 -44.02 24.28
Price-to-Free Cash Flow (P/FCF) Ratio
288.03 252.17 -25.02 -13.65 -12.54
Price-to-Operating Cash Flow Ratio
240.80 212.47 -25.14 -13.72 -12.90
Price-to-Earnings Growth (PEG) Ratio
-20.89 1.13 0.86 0.75 -0.23
Price-to-Fair Value
-75.71 -67.58 -72.81 -44.02 24.28
Enterprise Value Multiple
-155.88 -98.82 -27.56 -16.45 -12.41
Enterprise Value
12.58B 11.26B 7.99B 6.76B 6.57B
EV to EBITDA
-155.88 -98.82 -27.56 -16.45 -12.41
EV to Sales
17.52 16.27 21.98 25.36 128.35
EV to Free Cash Flow
294.00 258.03 -25.99 -14.40 -12.87
EV to Operating Cash Flow
245.80 217.41 -26.11 -14.47 -13.25
Tangible Book Value Per Share
-2.71 -2.75 -1.90 -2.67 4.61
Shareholders’ Equity Per Share
-2.65 -2.69 -1.83 -2.59 4.70
Tax and Other Ratios
Effective Tax Rate
-0.07 -0.07 -0.01 -0.02 >-0.01
Revenue Per Share
11.69 11.41 6.28 4.74 0.91
Net Income Per Share
-3.71 -3.61 -6.53 -8.55 -10.40
Tax Burden
1.07 1.07 1.01 1.02 1.01
Interest Burden
2.16 1.56 1.21 1.10 1.06
Research & Development to Revenue
0.42 0.41 0.84 1.55 7.42
SG&A to Revenue
0.44 0.00 0.78 0.97 4.22
Stock-Based Compensation to Revenue
0.12 0.00 0.26 0.25 1.25
Income Quality
-0.22 -0.24 0.81 0.97 0.85
Currency in EUR